Clinical Trials Directory

Trials / Completed

CompletedNCT06182631

Clinical Trial Testing Buzzy Bee vs Vapocoolant During IV Placement

A Randomized Clinical Trial of Buzzy Versus Vapocoolant in Pain Relief During Phlebotomy and IV Catheterization in the Pediatric ED

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
172 (actual)
Sponsor
State University of New York at Buffalo · Academic / Other
Sex
All
Age
6 Years – 18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to compare the anxiety and pain levels of patients when using Buzzy with ice, Vapocoolant, and placebo when inserting IV's line for IV fluids and/or phlebotomy in pediatric patients in the pediatric emergency department.

Conditions

Interventions

TypeNameDescription
DEVICEBuzzy BeeThe Buzzy is a vibrating palm-sized device with removable ice wings developed by MMJ Labs Atlanta, GA. It uses Melzack and Wall's Gait Control theorywhich asserts that activation of non-nociceptive fibers can interfere with signals from pain fibers thereby inhibiting pain.
DRUGVapocoolentVapocoolent is a volatile refrigerated liquid, ie ethyl chloride, which is supposed to feel like the skin is numb before insertion of the IV.
OTHERPlaceboA band will be placed on the arm before IV insertion for placebo effect.

Timeline

Start date
2019-07-15
Primary completion
2021-01-15
Completion
2021-01-15
First posted
2023-12-27
Last updated
2025-10-02
Results posted
2025-01-15

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06182631. Inclusion in this directory is not an endorsement.